Form 4 for KYMR Kymera Therapeutics, Inc.
Accepted 2023-08-08 00:00:00 ET · period of report 2023-08-08 · accession 0000950170-23-039894 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-08 | 2023-08-08 | KYMR | Mainolfi Nello | CEO, Dir | M - OptEx | $2.08 | +12.0K | 586.6K | +2% | +$25.0K |
| D | 2023-08-08 | 2023-08-08 | KYMR | Mainolfi Nello | CEO, Dir | M - OptEx | $0.00 | -12.0K | 2,368 | -84% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-08 | M | A | 12,000 | $2.08 | 586,570 | D | — | — | (F1) This number includes 870 shares acquired under the Registrant's employee stock purchase plan on May 31, 2023. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-08-08 | M | D | 12,000 | $0.00 | 2,368 | D | $2.08 · — to 2029-05-22 | 12,000 Common Stock | (F2) The shares underlying this stock option vested in forty-eight (48) equal monthly installments following the vesting commencement date of February 7, 2019, subject to the reporting person's continued employment through each vesting date. |